Brexit Will Continue To Impact UK Pharmaceutical Industry Access And Growth
Pharmaceuticals / United Kingdom / Fri 26 Apr, 2024
Key View
- UK drug shortages will likely persist due to ongoing post-Brexit access challenges, alongside wider regional supply chain issues.
- The UK's pharmaceutical sector will continue to present a less attractive prospect for investment compared to EU markets.
- Amidst Brexit's complexities, the UK government will continue to introduce new measures to